Member Info for The.Italian

morning bignose. interesting take on Recordati's"stance and possibly having its hands tied. had'nt thought of that. would make perfect sense. best wishes for Christmas and the New Year to you and all the others (well not quite all obviously!).lets see what 2023 brings.

ripley,as to fum,i have been invested since dec2019.im not going to go over the history since then as I've touched on it in other recent posts .tbh,if you are seriously contemplating investing you need to read all the RNSs since dec2019 (and perhaps a bit earlier) to get the full picture.i sold most of my holding following fum getting the CE mark for OTC in europe. made about 200%profit on a fairly sizeable investment.i have kept a small amount in( also traded a bit up and down) so that if it goes completely belly up i will still have done very well out of it. in some ways its like erp,in that its main (sole really) product is generally accepted as being effective within its own parameters and has an excellent safety profile.the product is not yet on the market lso no sales data. again i am fairly confident they will get FDA approval for OTX and this is due by end of Q1 2023.i expect a significant s/p spike on confirmation(how much is anyone's guess)and that a lot will sell out on the news.unlike ERP, fum have a pretty low cash burn and the bod receive what i regard as very modest remuneration. however,they have had a history of products promising much which has not materialised in practice. whether this will be different only time will tell.

afternoon all excellent summary on ERP bignose. my own view,which i think reflects also,big nose's, is that for those of us who have been invested for many years (from 2013 in my case and longer for bignose) we are approaching the point where it will be determined if the company is ever going to have a successful product or not, fda approval is still some way off, but we can see it on the horizon.eu sales should now be possible with the new manufacturer.the original problem of being only available RX as opposed to OTC,meant that sales were minimal. if we can get OTC approval in the US,(which i personally think we will,although to what time scale i can't say)then the sales' potential is significantly increased.as bignose says,the main problem is the company has never made any profits and has no cash to speak of.this will be partially addressed by the rights issue,but much of that is going to pay down existing debt.the ceo is,with respect,paid a ludicrous salary,totally out of proportion to the m/c of the company and its performance record.there is little likelihood that that will change. i am slightly encouraged that mellon is still prepared to put money in,but tbh,it's small change to him.that said,no one likes to lose money so i'm interpreting it as a very small measure of confidence in the prospects,but nothing more.personally i shall remainninvested until FDA approval,unless something very untoward happens(im pretty elderly!),but would not commit further funds of any substance in view of the history and lack of confidence in the bod. one point to remember is that it seems generally accepted that fortacin actually works and it has a very good safety profile(this is the reason im expecting FDa approval at end of day.the big questions are can they sell it in any volume and will they have enough money to get to the point?

morning bignose.it certainly makes you wonder doesn't it! really not sure what ripley is on about,but whatever it is i hope its gone well .dont think my trade has executed but can't be absolutely sure until later.

yes.agree with that bignose.going to be interesting to see the results of the RI. my guess is that mellon and co will end up with approx 50%.i imagine they will try and get some of the issue into non mellon hands just for appearance's sake,so probably won't get the full 59% possible.just a guess and probably completely wrong.

well my trade didn't execute.ive reset it for tomorrow,but not hopeful.

afternoon bignose.looks like they can't even get the exclusion right! lol

afternoon ripley.the reason i was of the opinion that the issue would not be available to uk residents is that it is expressly stated on page 19 of the prospectus(linked in my post of 9.58 last thursday )that holders in that jurisdiction (inter alia) would be excluded.it was also referenced in the original announcement about the rights issue that it would probably not be available to those of us in the uk..possibly the explanation is that the exclusion will only apply to uk residents who are registered in their own name,as opposed to holding(as i do) on a trading platform.

i have managed to place a trade today on my platform to sell the rights @ $0.01 hkd,but i will not know until tomorrow whether the trade will have gone through or not.

some pretty large trades now showing up.

evening Albert.hope you are well. agreed .probably a tad too early for news or promotion just yet.hoping for something early in the new year.have a very good christmas and new year.gla

glad to hear you've received the first payment at last,28. on the issue of progress in general,the last news was,i think,the ceo's podcast on 14th october.whilst i certainly haven't been expecting news every few days,i'm conscious that time is moving on towards the 31st march,so would expect some news,perhaps by way of advance publicity ,in january. although the price of algos has plummeted, apparently, over the last year or so, they have had good news in last few days from a link up with the italian govt regarding bond insurance. hopefully their plans for the napster token have not been impacted too adversely by the macro of the last few months. does anyone on here actually subscribe to napster, (i don't) as wondering if any promotional activity on the app itself? just in case anyone is interested in algorand generally here is an article from a few days ago.i think part of it was written earlier, as the reference to the world cup seems a little outdated and from other articles I've read,the world cup involvement hasn't been as successful as hoped,so the italian news is probably very welcome from their perspective.https://ambcrypto.com/algorand-algo-price-prediction-12/

just finished listening to the interview.extremely trenchant for this type of presentation.clearly sarah lowther isn't a graduate of the Katie Pilbeam school of interviewing! left very much in two minds after listening.hard to deny that rickette was floundering and somewhat defensive at times. however, overall encouraged to hear it being made very clear that the focus now is very clearly on textiles and construction.south korea pretty much(although perhaps not entirely)out of the picture,at least in the near term. pleased to hear confirmation that another four products are in sight and i found the references to UAE and Middle East encouraging. pretty clear,imo,that we shouldn't be expecting very much in the next accounts,but then i never was. what i am hoping for,but not necessarily expecting,is a strategic investment in some form from say QIA or other middle east entity, which would probably be transformational.but as i say ,hoping,not expecting. time will tell.

yes Okehurst. that is what i'm hoping.

is a 300% premium to the current s/p really likely? surely we need to be back at say £1 before we can realistically talk about £2. perfectly possible to see us back at a £1 if the figures come up to scratch,but until that happens bids with a £2 starting figure do not look realistic imo. would be very happy to be proved wrong of course.

hello ripley.no im not going to take up the rights ,but may try to sell the nil paid next week.will depend on whether i can get an actual quote that makes it worthwhile(what's quoted as the value in my account may well not be what i can get on an actual sale quote) and that my platform actually lets me do it(although it does look as if it's going to be possible in principle)

https://www.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote?sym=2993&sc_lang=en the nil paid rights are apparently trading at 0.01 HKD. i have managed to access my account (on my phone!) and i do appear to have an allocation despite being in the uk.i assume this is because my platform (interactive investor) is entitled on my behalf.havent attempted to sell nil paid as it's difficult to navigate on phone and i can't access all functions,but may consider next week.sorry if this is boring and irrelevant,but in view of my earlier comments about not expecting to be eligible,i felt i should qualify.

wondered if you would spot that.lol

that about says it all bignose.there are only 4 or 5 of us who postson here now and one of those thinks he's on another board! no offence hammer,only joking history of long suffering on here.they don't call it "endurance" for nothing!

evening arturo.interested to see you reference sigmaroc.ive been a holder for a while, unfortunately at a somewhat higher average than the current s/p.it was going great guns but got clobbered quite badly by the macro over last few months (particularly russia/ukraine situation). seems very well run and the recent trading update was very positive.i have high hopes of a good recovery and improvement next year,as the macro hopefully improves.aplogies for the off topic,but just interested to see someone else holding,as it's hardly ever posted on.

evening ripley. my erp shares are on a platform which allows me to trade on HXE and this afternoon i have had an email from it advising me of a corporate action (obviously relating to the rights issue).due to an ongoing IT problem i haven't been able to access the detail, but will be tackling the problem in next few days. i imagine it's just a formal notification about what is going on,as i don't think i can participate being a uk resident, even if i wished to.